Yolk or Egg Whites: What’s Better for Your Cholesterol?

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on email

For being one of the most nutrient-dense natural foods on the planet, eggs sure have taken a beating in the past few decades. The reason eggs have gotten such a bad rap is because they contain a fair amount of dietary cholesterol — about 185 mg per egg, almost all of which is housed in the yolk.

Decades ago, when the link between high cholesterol and cardiovascular disease was uncovered, medical experts advised limiting or completely avoiding the consumption of eggs (especially yolks), because dietary cholesterol could potentially raise blood cholesterol levels, therefore increasing the risk of heart problems.[R]

With the passage of time and the publication of lots of new data, much of the negative hype about cholesterol in eggs and its effects on the heart has been refuted.

A strong body of research has shown that egg yolks have a much smaller effect on LDL (bad) cholesterol and triglycerides than originally thought, and actually boost HDL (good) cholesterol levels. In addition, large, long-term studies published in various reputable journals disproved any claims that eggs raised the risk of stroke and cardiovascular disease in healthy people.[R] [R] [R]

Furthermore, a seemingly small but very significant effect that eggs have on cholesterol has far-reaching implications. The consumption of eggs seems to change the pattern of LDL cholesterol in the blood from smaller, denser particles to larger, more buoyant forms.[R] Smaller, denser particles are strongly associated with high LDL and triglycerides and low HDL, and are dangerous because they can squeeze between cells to reach the artery walls and cause blockages. So the larger the particles are, the better.

This finding was one of many factors that led researchers at the University of  Connecticut to examine eggs’ role in improving cholesterol and insulin sensitivity in individuals with metabolic syndrome.[R] In particular, they were curious to see how eggs affected atherogenic dyslipidemia, a strong factor associated with metabolic syndrome and heart disease. It is a condition that comprises a triad of increased blood concentrations of small, dense LDL particles, decreased HDL particles, and increased triglycerides.

Researchers followed 37 men and women aged 30–70 years who had metabolic syndrome for a 12-week period. The participants were given guidelines to follow a moderately carbohydrate-restricted diet for the entire 12 weeks (25 percent to 30 percent carbs, 25 percent to 30 percent protein, 45percent to 50 percent fat).

In addition, they were randomly divided into two groups. Researchers instructed the first group to consume three whole eggs per day, and the second group to consume the equivalent amount (about 1/2 cup) of yolk-free egg substitute (which is basically nutrient-fortified egg whites).

Each daily serving of whole eggs contained 534 mg of cholesterol, 0 g of carbohydrates, 16 g of protein, 12 g of fat and about 186 calories. In contrast, the daily serving of egg substitute contained about 2 g of carbohydrates, 14 g of protein and about 60 calories.

 (Note: The study authors did not mention how much cholesterol or fat was in the egg substitute. This is likely because most egg substitutes do not contain cholesterol or fat, or at least very minimal amounts since the yolk is removed.)

Eggs & Cholesterol Results

After 12 weeks, both groups experienced a 4 percent weight loss. But the main finding was that the combination of moderate carbohydrate restriction and whole egg intake improved atherogenic dyslipidemia and insulin resistance in the participants.

All the participants experienced decreased triglycerides and increased HDL cholesterol, as well as increased LDL particle size. However, those eating the whole eggs ended up with greater increases in HDL and LDL particle size, as well as larger reductions in total very-low density lipoproteins (VLDL), which contain the highest amount of triglycerides.

Researchers concluded that whole egg consumption, along with a moderately carbohydrate-restricted diet, provides improvements in lipid profiles and insulin resistance in individuals with metabolic syndrome.

Eat Your Eggs Whole

Finally, whole eggs are truly getting the respect they deserve! All the attention surrounding cholesterol content has completely overshadowed the fact that eggs are nutritional powerhouses — with the majority of the nutrients residing in the yolk.

Ironically, egg yolks are a good source of heart-healthy omega-3 fatty acids (particularly DHA) and monounsaturated fats. And eggs as a whole, but especially the yolks, are a rich source of folate, vitamin A, selenium, potassium, calcium, choline, and the eye-protective carotenoids zeaxanthin and lutein. And, of course, as any bodybuilder will verify, eggs are a substantial source of muscle-building protein.

Simply put, for most people, there’s no reason to avoid whole eggs or to use egg substitutes. Now this recommendation rings exceptionally true for those who are dealing with metabolic syndrome. If you’re one of those people, feel good about enjoying eggs as nature intended — yolk and all.

Share This Article

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on email
main icone

Scientific References

1. Dai YL, Luk TH, Yiu KH, et al. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis. 2011 Jun;216(2):395-401.

2. Mehrabani, S., Askari, G., Miraghajani, M., Tavakoly, R., & Arab, A. (2019). Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies. Complementary Therapies in Medicine, 43, 181–187. doi: 10.1016/j.ctim.2019.01.022

3. Dumont, M., Kipiani, K., Yu, F., Wille, E., Katz, M., Calingasan, N. Y., … Beal, M. F. (2011). Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimers Disease. Journal of Alzheimers Disease, 27(1), 211–223. doi: 10.3233/jad-2011-110209

4. Mezawa M, Takemoto M, Onishi S, et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study. Biofactors. 2012 Aug 8.

5. Hernández-Camacho, J. D., Bernier, M., López-Lluch, G., & Navas, P. (2018). Coenzyme Q10 Supplementation in Aging and Disease. Frontiers in Physiology, 9. doi: 10.3389/fphys.2018.00044

6. Crowley D.C., et al. “Bioavailability and Health Effects of CoQ10 in Healthy Human Adults.” May 11, 2006.

7. Kalén, A., Appelkvist, E.-L., & Dallner, G. (1989). Age-related changes in the lipid compositions of rat and human tissues. Lipids, 24(7), 579–584. doi: 10.1007/bf02535072

8. Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy. (2011). Iranian Journal of Kidney Diseases. doi: 21368390

9. Vargiu, R., Littarru, G. P., Faa, G., & Mancinelli, R. (2008). Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters. BioFactors, 32(1-4), 135–144. doi: 10.1002/biof.5520320116

10. Johansson, P., Dahlström, Ö., Dahlström, U., & Alehagen, U. (2015). Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined. Results from a double blind, placebo-controlled prospective study. The Journal of Nutrition, Health & Aging, 19(9), 870–877. doi: 10.1007/s12603-015-0509-9

11. Adarsh, K., Kaur, H., & Mohan, V. (2008). Coenzyme Q10(CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM). BioFactors, 32(1-4), 145–149. doi: 10.1002/biof.5520320117

12. Burke, B. E., Neuenschwander, R., & Olson, R. D. (2001). Randomized, Double-Blind, Placebo- Controlled Trial of Coenzyme Q10 in Isolated Systolic Hypertension. Southern Medical Journal, 94(11), 1112–1117. doi: 10.1097/00007611-200111000-00015

13. Zhai, J., Bo, Y., Lu, Y., Liu, C., & Zhang, L. (2017). Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. Plos One12(1). doi: 10.1371/journal.pone.0170172

14. Lewin, A., & Lavon, H. (1997). The effect of coenzyme Q10 on sperm motility and function. Molecular Aspects of Medicine, 18, 213–219. doi: 10.1016/s0098-2997(97)00036-8

15. Preethi Srikanthan, Arun S. Karlamangla. Muscle Mass Index as a Predictor of Longevity in Older-Adults. The American Journal of Medicine, 2014; DOI: 10.1016/j.amjmed.2014.02.007

16. Folkers, K., & Simonsen, R. (1995). Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochimica Et Biophysica Acta (BBA) – Molecular Basis of Disease, 1271(1), 281–286. doi: 10.1016/0925-4439(95)00040-b

17. Farsi, F., Mohammadshahi, M., Alavinejad, P., Rezazadeh, A., Zarei, M., & Engali, K. A. (2015). Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of the American College of Nutrition, 35(4), 346–353. doi: 10.1080/07315724.2015.1021057